Skip to content

NIALI: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

NIALI

BE 0874.244.073
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€199,804
2024 · €206,001-€6,197
Equity
€851,125
2024 · €691,321+€159,804
Cash
€277,585
2024 · €316,204-€38,620
Balance sheet total
€1.4m
2024 · €1.3m+€124,699

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€139,010

    up €139,010 (+27.3%), from €508,558 to €647,568

    of which Other amounts receivable: +€101,044

  • Stocks and contracts +€39,899

    up €39,899 (+12.3%), from €323,431 to €363,330

  • Cash -€38,620

    down €38,620 (-12.2%), from €316,204 to €277,585

    mainly Other debts (-€143,363) and Receivables within one year (-€139,010)

  • Tangible fixed assets -€16,034

    down €16,034 (-12.8%), from €125,067 to €109,034

    of which Plant, machinery and equipment: -€17,525

Equity and liabilities
  • Profit (loss) carried forward +€159,804

    up €159,804 (+26.1%), from €611,543 to €771,347

  • Other debts -€143,363

    down €143,363 (-35.0%), from €409,988 to €266,625

  • Trade debts +€105,677

    up €105,677 (+75.2%), from €140,550 to €246,228

Income statement
  • Gross operating margin +€37,041

    up €37,041 (+8.1%), from €455,143 to €492,184

  • Staff costs +€23,401

    up €23,401 (+12.1%), from €192,705 to €216,106

  • Taxes +€16,884

    up €16,884 (+41.8%), from €40,398 to €57,282

  • Financial income -€8,565

    down €8,565 (-27.7%), from €30,952 to €22,386

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €206,001
Gross operating margin +€37,041
Staff costs -€23,401
Depreciation +€845
Other operating charges -€23
Financial income -€8,565
Financial charges +€4,791
Taxes -€16,884
Result 2025 €199,804

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€8,271
Investment -€6,890
Financing -€40,000
Cash 2024 €316,204
Net result for the year +€199,804
Depreciation +€22,924
Stocks and contracts -€39,899
Receivables within one year -€139,010
Deferred charges and accrued income -€443
Trade debts +€105,677
Tax, wage and social debts +€3,161
Other debts -€143,363
Accrued charges and deferred income -€581
Investment in fixed assets (net) -€6,890
Contributions, distributions and other -€40,000
Cash 2025 €277,585
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,282,263 €1,406,962 +€124,699 +9.7%
Fixed assets 21/28 €125,067 €109,034 -€16,034 -12.8%
Tangible fixed assets 22/27 €125,067 €109,034 -€16,034 -12.8%
Land and buildings 22 €8,642 €6,699 -€1,944 -22.5%
Plant, machinery and equipment 23 €94,931 €77,407 -€17,525 -18.5%
Other tangible fixed assets 26 €21,493 €24,928 +€3,435 +16.0%
Current assets 29/58 €1,157,196 €1,297,928 +€140,732 +12.2%
Stocks and contracts in progress 3 €323,431 €363,330 +€39,899 +12.3%
Stocks 30/36 €323,431 €363,330 +€39,899 +12.3%
Amounts receivable within one year 40/41 €508,558 €647,568 +€139,010 +27.3%
Trade receivables 40 €140,499 €178,466 +€37,966 +27.0%
Other amounts receivable 41 €368,058 €469,102 +€101,044 +27.5%
Cash at bank and in hand 54/58 €316,204 €277,585 -€38,620 -12.2%
Deferred charges and accrued income 490/1 €9,003 €9,445 +€443 +4.9%
Total equity and liabilities 10/49 €1,282,263 €1,406,962 +€124,699 +9.7%
Equity 10/15 €691,321 €851,125 +€159,804 +23.1%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €17,778 €17,778 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €11,578 €11,578 = 0.0%
Profit (loss) carried forward 14 €611,543 €771,347 +€159,804 +26.1%
Amounts payable 17/49 €590,942 €555,836 -€35,105 -5.9%
Amounts payable within one year 42/48 €587,854 €553,330 -€34,524 -5.9%
Trade debts 44 €140,550 €246,228 +€105,677 +75.2%
Suppliers 440/4 €140,550 €246,228 +€105,677 +75.2%
Taxes, remuneration and social security 45 €37,316 €40,477 +€3,161 +8.5%
Taxes 450/3 €5,027 €4,406 -€621 -12.4%
Remuneration and social security 454/9 €32,289 €36,072 +€3,782 +11.7%
Other amounts payable 47/48 €409,988 €266,625 -€143,363 -35.0%
Accrued charges and deferred income 492/3 €3,088 €2,507 -€581 -18.8%
Non-recurring operating income 76A €537 - -€537
Remuneration, social security and pensions 62 €192,705 €216,106 +€23,401 +12.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €23,769 €22,924 -€845 -3.6%
Other operating charges 640/8 €1,443 €1,466 +€23 +1.6%
Gross operating margin 9900 €455,143 €492,184 +€37,041 +8.1%
Operating profit (loss) 9901 €237,227 €251,688 +€14,462 +6.1%
Financial income 75/76B €30,952 €22,386 -€8,565 -27.7%
Recurring financial income 75 €30,952 €22,386 -€8,565 -27.7%
Financial charges 65/66B €21,779 €16,988 -€4,791 -22.0%
Recurring financial charges 65 €21,779 €16,988 -€4,791 -22.0%
Profit (loss) for the period before taxes 9903 €246,399 €257,086 +€10,687 +4.3%
Income taxes 67/77 €40,398 €57,282 +€16,884 +41.8%
Profit (loss) for the period 9904 €206,001 €199,804 -€6,197 -3.0%
Profit (loss) for the period to be appropriated 9905 €206,001 €199,804 -€6,197 -3.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.